Stock Overview

Lincoln Pharmaceuticals Share Price

Lincoln Pharmaceuticals Share Price

581.4
+1.95 (0.34%)
NSE
BSE
29 Jul, 2026 • 03:30 PM
NSE: LINCOLN | Pharmaceuticals | Small Cap
Buywith MTF at 1x leverage

Lincoln Pharmaceuticals Annualised Returns

1 Year

6.79%Increase

3 Years

13.22%Increase

5 Years

9.71%Increase

10 Years

13.02%Increase

Lincoln Pharmaceuticals Share Price Today


As of 29 Jul 2026, Lincoln Pharmaceuticals share price is ₹581.4. The stock opened at ₹582.2 and had closed at ₹579.4 the previous day. During today’s trading session, Lincoln Pharmaceuticals share price moved between ₹580.50 and ₹589.15, with an average price for the day of ₹584.83. Over the last 52 weeks, the stock has recorded a low of ₹440.00 and a high of ₹770.00. In terms of performance, Lincoln Pharmaceuticals share price has increased by 29.5% over the past six months and has increased by 6.79% over the last year.

Lincoln Pharmaceuticals Stock Performance

1W Return0.77%
1M Return-7.07%
6M Return30.89%
1Y Return6.90%
3Y Return33.53%
Today's High₹589.15
Today's Low₹580.5
52-Week High₹770
52-Week Low₹440
Prev. Close₹579.45
Open₹582.20
Face Value₹10
Mkt Cap (Cr.)₹1,165
PE Ratio13.23

Lincoln Pharmaceuticals Share Price Chart

Lincoln Pharmaceuticals Company background

Founded in: 1995
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes antiinfective, respiratory system, gynecology, cardio CNS, antidiabetic, anti malaria, among others.The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake inhouse testing of its products for better quality control and RD. It came out with a public issue in Feb.96 to partfinance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 202122, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022. The Company commenced commercial production in Mehsana in FY 2025.

Lincoln Pharmaceuticals Financial Highlights


For the full year FY2026–2027, revenue reached ₹704.48 crore and profit touched at ₹87.89 crore.
Lincoln Pharmaceuticals SIP Returns Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹3,87,341 in 5 years with a gain of ₹87,341 (+29.11%)
Start SIP

Lincoln Pharmaceuticals Fundamental

Market Cap (in crs)

1,164.53

Face Value

10

Turnover (in lacs)

38.51

Key Metrics

Qtr Change %
32.14% Gain from 52W Low
-10
Dividend yield 1yr %
Below industry Median
0.3

Lincoln Pharmaceuticals Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...

Lincoln Pharmaceuticals Result Highlights

  • Lincoln Pharmaceuticals reported a 9.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 1.2%.

  • Its expenses for the quarter were down by 7.0% QoQ and up 5.9% YoY.

  • The net profit decreased 21.1% QoQ and decreased 25.9% YoY.

  • The earnings per share (EPS) of Lincoln Pharmaceuticals stood at 10.4 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Lincoln Pharmaceuticals Technical Analysis

Moving Averages Analysis
581.4
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
583.50
10 EMA
589.60
12 EMA
591.90
20 EMA
599.60
26 EMA
604.30
50 EMA
614.00
100 EMA
608.40
200 EMA
592.80
Delivery & Volume
Loading chart...

Delivery Volume %

Day

56.30%

Week

62.80%

Month

57.60%

Delivery & Volume

Resistance & Support

580.68
Pivot
Resistance
First Resistance
588.07
Second Resistance
596.68
Third Resistance
604.07
Support
First Support
572.07
Second support
564.68
Third Support
556.07
Relative Strength Index
36.96
Money Flow Index
48.83
MACD
-12.42
MACD Signal
-10.79
Average True Range
17.98
Average Directional Index
19.58
Rate of Change (21)
-7.38
Rate of Change (125)
25.87

Lincoln Pharmaceuticals Peer comparison

Compare

Lincoln Pharmaceuticals Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
49.8%
Foreign Institutions
4.6%
Domestic Institutions
0.3%
Public
45.4%

Lincoln Pharmaceuticals FII Holdings & DII Holdings

Lincoln Pharmaceuticals Latest News

06 JUL 2026

Lincoln Pharmaceuticals - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

24 JUN 2026

Lincoln Pharmaceuticals - 531633 - Closure of Trading Window

01 JUN 2026

Q4FY26 & FY26 Result Announced for Lincoln Pharmaceuticals .

Lincoln Pharmaceuticals Share Price FAQs

Lincoln Pharmaceuticals share price is ₹581.4 in NSE and ₹580.5 in BSE as on 29/7/2026.

Lincoln Pharmaceuticals share price in the past 1-year return was 6.9. The Lincoln Pharmaceuticals share hit a 1-year low of Rs. 440 and a 1-year high of Rs. 770.

The market cap of Lincoln Pharmaceuticals is Rs. 1164.53 Cr. as of 29/7/2026.

The PE ratios of Lincoln Pharmaceuticals is 13.23 as of 29/7/2026.

The PB ratios of Lincoln Pharmaceuticals is 1.53 as of 29/7/2026

You can easily buy Lincoln Pharmaceuticals shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Lincoln Pharmaceuticals share price is ₹770 and ₹440 as of 29/7/2026.

Please be aware that Lincoln Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.